Ken Rosenthal’s eminently reasonable position on Jeff Bagwell and steroids


Not sure why it’s so hard for Hall of Fame voters to get on board with the ideas that (a) it’s not fair to assume someone was on steroids when there is no evidence of it; and (b) Jeff Bagwell, on the merits, posted a Hall of Fame career. But considering it’s highly unlikely he’ll be inducted this year, a healthy number of voters have a hard time with those concepts.

Thank goodness for Ken Rosenthal, then.  I don’t agree with everything he says in his Hall of Fame column — what fun would that be? — but how anyone can disagree with this is beyond me.

When voting, one should only consider the facts at hand. If Bagwell is later revealed to have been a user, maybe I will stop voting for him, if he isn’t already in the Hall. There is little doubt that he is deserving otherwise, unless you’re somehow unimpressed by his .408 on-base percentage and .540 slugging mark, not to mention his baserunning, defense at first base and leadership of the Astros during his 15-year career … For now, all I know is one thing: I’m not withholding votes based on hearsay and innuendo.


Chris Sale will start on Opening Day for Red Sox

Bob Levey/Getty Images

No surprise here: Chris Sale will start on Opening Day for the Red Sox, Pete Abraham of The Boston Globe reports. The Red Sox open the season on March 29 in Tampa Bay against the Rays. Sale will oppose Chris Archer.

Sale, 28, is the fifth different Opening Day starter the Red Sox have had in as many years, preceded by Rick Porcello, David Price, Clay Buchholz, and Jon Lester. Sale started on Opening Day for the White Sox in 2013, ’14, and ’16.

Sale finished second in AL Cy Young Award balloting last year and finished ninth for AL MVP. He went 17-8 with a 2.90 ERA and a 308/43 K/BB ratio in 214 1/3 innings. Sale and Clayton Kershaw (2015) are the only pitchers to strike out 300 or more batters in a season dating back to 2003.